HON vs ORCL: Which Is the Better Buy?

Side-by-side comparison of Honeywell International Inc. and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Honeywell International Inc. Β· Industrials
$212.55
-8.5% upside to fair value
Med Conviction Grade C
VS
Oracle Corporation Β· Technology
$149.12
+45.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
ORCL has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric HON ORCL
Current Price $212.55 $149.12
Fair Value Estimate $194.50 $216.22
Upside to Fair Value -8.5% +45.0%
Market Cap $67.4B $429.5B
Forward P/E β€” β€”
EV / EBITDA 7.4x 14.6x
Price / Sales 1.9x 6.0x
Price / FCF 16.4x β€”
Revenue Growth YoY -6.1% +29.6%
Gross Margin 36.6% 63.9%
Operating Margin 14.1% 32.4%
Return on Equity 41.7% 42.6%
Dividend Yield 2.09% 1.34%
FCF Yield 6.11% β€”
Analyst Consensus Buy Strong Buy
Investment Thesis
HON β€” Honeywell International Inc.
Honeywell International Inc. is a 101,000-employee diversified industrial technology and manufacturing conglomerate, led by CEO Vimal Kapur, spanning Aerospace, Building Technologies, Performance Materials and Technologies, and Safety and Productivity Solutions. Business quality is solid but not exceptional: the company carries a durable intangible-asset and switching-cost moat in aerospace avion…
ORCL β€” Oracle Corporation
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
Metric HON ORCL
Zone Low $145.88 $162.16
Zone High $165.32 $183.79
In Buy Zone? No Yes
← HON Research    ORCL Research β†’    All Research